Pfizer Inc., (NYSE:PFE) and Synthon, have entered into an agreement whereby Pfizer has acquired the exclusive commercialisation rights in the United States to glatiramer acetate, a potential generic version of the originator medicine Copaxone for the treatment of relapsing remitting multiple sclerosis (RRMS). Pfizer Inc. (NYSE:PFE) belongs to Healthcare sector. Its net profit margin is 18.50% and weekly performance is -0.80%. On last trading day company shares ended up $35.17. Pfizer Inc. (NYSE:PFE) distance from 50-day simple moving average (SMA50) is 2.70%.
Merck & Co. Inc. (NYSE:MRK) announced that the Board of Directors has declared a quarterly dividend of $0.45 per share of the company’s common stock for the fourth quarter of 2015. Payment will be made on October 7, 2015, to shareholders of record at the close of business on September 15, 2015. Merck & Co. Inc. (NYSE:MRK) shares decreased -1.13% in last trading session and ended the day at $58.43. MRK Gross Margin is 69.20% and its return on assets is 9.70%. Merck & Co. Inc. (NYSE:MRK) quarterly performance is -2.36%.
On 29 July, GlaxoSmithKline plc (NYSE:GSK) reported Profit excluding certain items was £1.3 billion ($2.1 billion), or 17.3 pence a share, down from £1.4 billion, or 19.1 pence a share, a year ago, the London-based company said in a statement. Analysts expected 16.9 cents a share, based on the average of 13 estimates compiled by Bloomberg. On 06 August, GlaxoSmithKline plc (NYSE:GSK) shares increased 1.65% and was closed at $44.90. GSK EPS growth in last 5 year was -12.10%. GlaxoSmithKline plc (NYSE:GSK) year to date (YTD) performance is 7.98%.
Johnson & Johnson (NYSE:JNJ) announced that its Board of Directors has declared a cash dividend for the third quarter of 2015 of $0.75 per share on the company’s common stock. The dividend is payable on September 8, 2015 to shareholders of record at the close of business on August 25, 2015. The ex-dividend date is August 21, 2015.Johnson & Johnson (NYSE:JNJ) ended the last trading day at $99.07. Company weekly volatility is calculated as 1.02% and price to cash ratio as 8.77. Johnson & Johnson (NYSE:JNJ) showed a weekly performance of -0.77%.
On 29 July, AbbVie Inc. (NYSE:ABBV) told the Delaware Supreme Court that the Chancery Court was right to toss shareholders’ records demands investigating the failed $55 billion merger with Shire PLC, which fell apart amid an Obama administration crackdown on tax-driven inversions, arguing there was no proper purpose for the probe. AbbVie Inc. (NYSE:ABBV) shares decreased -1.51% in last trading session and ended the day at $69.24. ABBV Gross Margin is 80.80% and its return on assets is 7.50%. AbbVie Inc. (NYSE:ABBV) quarterly performance is 7.81%.